维普期刊资源整合服务平台（V6.5）

51篇 您的检索式：作者名="Preston SL"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	The new stem cell biology : something foreveryone 显示文摘	Preston SL Alison MR Forbes SJ	2003	J Clin Pathoh : Mol pathol2003，56，2：	1
2	Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials显示文摘	Preston SL Drusano GL Berman AL	1998	JAMA1998，279，2：	1
3	Oxidative stress and the ovary显示文摘	Behrman HR Kodaman PH Preston SL	2001	J Soc Gynecol Investig2001，8，1：	1
4	The importance of appropriate antimicrobial dosing: pharmacokinetic and pharmacodynamic considerations 显示文摘	Preston SL	2004	Ann Pharmacother2004，38，9：	1
5	Oxidative stress and ovary显示文摘	Behrman HR Kodaman PH Preston SL	2001	J Soc Gynecol lnvestig2001，，：	1
6	Pharmacodynamics of Levofloxacin: A Paradigm for early clinical trials显示文摘	Preston SL Drumno GL Berman AL	1998	JAMA1998，279，：	1
7	Use of preclinical data for selection of a phase II/III dose for evernimicin and identification of a preclinical MIC breakpoint显示文摘	Drusano GL Preston SL Hardalo C	2001	Antimicrob Agents Chemother2001，45，：	1
8	Mechanisms of disease :flora stem cells to eolorectal cancer显示文摘	McDonad SAC Preston SL Lovell MJ	2006	Nature Clinical Practice Gastroenterology Hepatology2006，3，5：	1
9	Radiation effects on breast cancer risk:a pooled analysis of eight cohorts显示文摘	Preston DL Mattsson A Holmberg E et sl	2002	Radiat Res2002，158，2：	1
10	A 48 week duration of therapy with pegylated interferon alpha 2b plus ribavirin may be too short to maximize long-term response among patients infected with genotype-1 hepatitisC virus显示文摘	Drusano GL Preston SL	2004	J Infect Dis2004，89，6：	1
11	Use of preclinical data forse-lection of a phase ]I / Ill dose for evernimicin and identifi- cation of a preclinical MIC breakpoint显示文摘	Drusano GL Preston SL HardaLo (2	2001	Antimicrob Agents Chemother2001，45，1：	1
12	Pharmacodynamics of levofloxacin: A paradigm for early clinical trials显示文摘	Preston SL Drumno GL Berman AL	1998	JAMA1998，27，9：	1
13	Pharmacodynamics of levofloxacin,a new paradigm for early clinical trials显示文摘	Drusano GL Berman AL	1998	JAMA1998，279，2：	1
14	The new stem cell biology: something for everyone 显示文摘	Preston SL Alison MR Forbes SJ	2003	Mol Pathol2003，56，2：	1
15	A population phar- maeokinetie analysis of the penetration of the prostate by levofloxa- cin 显示文摘	Drusano GL Preston SL Van Guilder M	2000	Antimicrnb Agents Chemother2000，44，：	1
16	Use of preclinical data for se- lection of a phase II/III dose for evemimicin and identification of a preclinical MIC breakpoint显示文摘	Drusano GL Preston SL Hardalo C	2001	Antimicrob Agents Chemother2001，45，1：	1
17	The new stem cell biology:Something for everyone显示文摘	Preston SL Alison MR Forbes SJ		0，，02：	1
18	Antioxidants reversibly inhibit spontaneous resumption of meiosis 显示文摘	Takami M Preston SL Toyloy VA	1999	Am J Physiol1999，276，1：	1
19	Pharmacokinetics and absolute bioavailabihty of ribavirin in healthy volunteers as determined by stable-isotope methodology显示文摘	Preston SL Drusano GL Glue P	1999	Antimicrob Agents Chernother1999，43，10：	1
20	Phannacokinetics and absolute bioavailability of ribavirin in healthy volunteers as determined by stable-isotope methodology 显示文摘	Preston SL Drusano GL Glue P	1999	Antimicrob Agents Chemother1999，43，10：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示